Login to Your Account

NewCo News

Oxagen Spinout Atopix to Advance Allergy Pipeline

By Nuala Moran
Staff Writer

Wednesday, June 5, 2013
LONDON – A new company has been spun out of genomics pioneer Oxagen Ltd. to take forward the lead compound OC459 in fresh indications.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription